A very interesting study came from the comprehensive analysis of mutation in glioblastoma multiforme (GBM) by the Hopkins team in 2008, which led to the discovery of a recurrent mutation R132H in isocitrate dehydrogenase 1 (IDH1) and the mutation was shown to be associated with better survival (51). Here, IDH1 is linked to glioblastoma.